Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). [electronic resource]
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology May 2012
- 1620-7 p. digital